HCR 577 Course Reflection
HCR 577 Course Reflection
I thought I knew a lot about regulation before I began HCR 577: Global Regulatory Affairs, because I am a Food Safety Investigator with the FDA with more than two decades of experience. I work to ensure the safety of food products through regulation enforcement, inspections, and the control of unsafe products from entering the market. As a result, I began the course feeling fairly comfortable. But the course demonstrated to me that the regulation of drugs and biologics is much more complicated and international than I thought.
One key takeaway was the Common Technical Document (CTD), which is used to structure global regulatory submissions in a standardized way. I previously had more experience in the food area of regulation, which is more focused on inspections, surveillance and enforcement. Through the CTD lessons, I learned that drug approval is based on scientific data in Modules 1 to 5 (administrative information, quality, nonclinical and clinical studies). The Aducanumab project gave me insight into how these contribute to decision-making. It made me realize that regulation is not just about compliance, but also about trust.
By carefully following the drug Aducanumab, I learned more about the regulatory system. This was a drug that was successfully used to treat Alzheimer’s disease, but it was a controversial drug with respect to its safety, efficacy and value. This drug helped me understand the reality that when science is not black and white, regulation is tricky. Similarly, in food safety, sometimes we must act quickly to ensure human safety, even if we do not know everything. Aducanumab taught me that regulators need to weigh innovation against safety and public trust. This insight resonated strongly with me because food safety investigators also have a responsibility to protect lives while being fair and objective.
Durrant (2001) describes how manufacturers and regulators must ensure safety, efficacy and appropriate post-approval monitoring of drugs. I found this very relevant to food safety, too. Companies can follow the rules, but regulators must make sure they are doing so and monitor the products after they are launched. Pharmaceutical post-marketing surveillance is similar to food recall investigations and follow-up inspections in my field. Both rely on trust, openness and responsiveness to potential risks. This analogy taught me that regulatory science in any industry has a common goal: to protect public health.
The second lesson was understanding how international regulations vary in the US, Europe, Asia and emerging markets. I was familiar mostly with FDA processes, but this course taught me how global harmonization through ICH guidelines helps ensure that things are consistent all around the world. I learned that public safety is no longer regional; it is global. Every day, food and drugs travel across borders. As a food safety professional, I am more efficient when I have knowledge of international standards because there is contamination, recalls and non-compliance that can cross borders. This course has given me valuable insight into regional inspections and global regulation.
I also want to thank my professor, Dr. Clare Elser, for her contribution to my education. Her input and feedback helped me understand and translate complex concepts and apply them in real life. She fostered a learning environment that was more about thinking critically than routine learning. Her comments on the coursework, particularly the CTD modules, helped me to be more detail-oriented and confident in working with complex regulatory documents. She encouraged us to think like real regulatory professionals, and that added value to the course. I liked how she related coursework to real regulatory issues, which helped me better apply the course material to my work at the FDA.
I also discovered something about myself. I discovered that I like the investigative aspects of regulatory science even more than I suspected. The CTD for Aducanumab required a lot of attention to detail, patience and critical thinking. It was like a jigsaw puzzle where all the pieces must fit together. I enjoyed putting it all together and seeing how one small regulatory decision affects science, ethics and society. I was reminded of what drew me into this line of work. I do more than regulate, I protect.
One thing I would do differently is focus more on the early part of the course on the clinical trial process and drug terminology. Initially, the transition from food to drug regulation was like a new language. Words such as accelerated approval, biologics license applications and post-marketing commitments were hard to grasp. As I learned these, the course became easier. I came to understand that asking relevant questions is not a weakness, but rather it is part of the learning process.
In summary, this class achieved its learning objectives because it allowed me to compare approval systems around the world, understand CTD submissions and assess the regulatory responsibility of various countries. It also helped me see myself as a professional. I am now a Food Safety Investigator working for the FDA, but my focus is on regulation that involves food, drugs, biologics and trust. This course did not just educate me on pharmaceutical regulation; it educated me on the purpose of regulation in general. Whether it is inspecting a food plant or reviewing the approval of a complicated drug such as Aducanumab, it is all about protecting human health through the application of science, integrity and ethics.
HCR 577 Course Reflection
